Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.86 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.82 |
| ▸ | TP53 | P04637 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.73 |
| ▸ | RARB | P10826 | 3/20 | 0.69 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.65 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.62 |
| ▸ | THRA | P10827 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3968275 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL2039230 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL2354201 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL15177361 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL10497781 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL10499017 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL762326 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL2039972 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL10497130 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B | |
| SCHEMBL2035476 | 1.00 | GAA (0.86) | GAAL3MBTL1TP53TSHRPLA2G4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113387790-B | Preparation method of chloroalkoxy-1, 3-diphenyl-beta-diketone | 佛山华铕光电材料股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-113387790-A | Preparation method of chloroalkoxy-1, 3-diphenyl-beta-diketone | 佛山华铕光电材料股份有限公司 | 2021-09-14 | — | — | CN | claimed |
| CN-113387790-B | Preparation method of chloroalkoxy-1, 3-diphenyl-beta-diketone | 佛山华铕光电材料股份有限公司 | 2022-08-05 | — | — | CN | disclosed |
| CN-113387790-A | Preparation method of chloroalkoxy-1, 3-diphenyl-beta-diketone | 佛山华铕光电材料股份有限公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-106715479-B | Catalyst for polymerization of conjugated diene, conjugated diene polymer, modified conjugated diene polymer, polybutadiene, and composition containing same | 宇部兴产株式会社 | 2019-07-23 | — | — | CN | disclosed |
| US-10053526-B2 | Catalyst for conjugated diene polymerization, conjugated diene polymer, modified conjugated diene polymer, polybutadiene, and compositions comprising foregoing | UBE INDUSTRIES, LTD. (JP) | 2018-08-21 | — | — | US | disclosed |
| EP-2978820-B1 | WAVELENGTH CONVERSION FILMS WITH MULTIPLE PHOTOSTABLE ORGANIC CHROMOPHORES | NITTO DENKO CORP (JP) | 2018-03-21 | — | — | EP | disclosed |
| EP-2941474-B1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR WAVELENGTH CONVERSION | NITTO DENKO CORP (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-20170158786-A1 | CATALYST FOR CONJUGATED DIENE POLYMERIZATION, CONJUGATED DIENE POLYMER, MODIFIED CONJUGATED DIENE POLYMER, POLYBUTADIENE, AND COMPOSITIONS COMPRISING FOREGOING | UBE INDUSTRIES, LTD. (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20160108310-A1 | WAVELENGTH CONVERSION FILMS WITH MULTIPLE PHOTOSTABLE ORGANIC CHROMOPHORES | NITTO DENKO CORPORATION (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20150340519-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR WAVELENGTH CONVERSION | NITTO DENKO CORPORATION (JP) | 2015-11-26 | — | — | US | disclosed |
| US-20050176808-A1 | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | GENFIT (FR) | 2005-08-11 | — | — | US | disclosed |
| US-20050171149-A1 | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof | GENFIT (FR) | 2005-08-04 | — | — | US | disclosed |
| EP-1525177-A1 | SUBSTITUTED 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES AND PREPARATION AND USES THEREOF | Genfit (FR) | 2005-04-27 | — | — | EP | disclosed |
| EP-1519908-A2 | COMPOSITION BASED ON SUBSTITUTED 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES, PREPARATION AND USES THEREOF | Genfit (FR) | 2005-04-06 | — | — | EP | disclosed |
| WO-2005005369-A1 | PREPARATION OF 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES | GENFIT (FR) | 2005-01-20 | — | — | WO | disclosed |
| WO-2004005243-A2 | COMPOSITION BASED ON SUBSTITUTED 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES | GENFIT (FR) | 2004-01-15 | — | — | WO | disclosed |
| WO-2004005233-A1 | SUBSTITUTED 1,3-DIPHENYLPROP-2-EN-1-ONE DERIVATIVES AND PREPARATION AND USES THEREOF | GENFIT (FR) | 2004-01-15 | — | — | WO | disclosed |
| EP-0328669-A1 | CHALCONE DERIVATIVE COMPOUNDS | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1989-08-23 | — | — | EP | disclosed |
| CN-85101534-A | The method of curable synthetic resin composition and manufacturing multipolymer | — | 1987-01-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176808-A1 | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | PGF, PTGS1, PTGES3 | GAA 1242/4885L3MBTL1 4634/4885TP53 3187/4885 |
| US-20050171149-A1 | Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof | BRCA1, LOXL1, APOL1 | GAA 444/4885L3MBTL1 639/4885TP53 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.